Table 1. Ever Smoker Patient data.
Sample | Site a | Sex | Age | Tobacco/Betel b | Ethanol c | Path. Stage | Grade d | Immune State |
OSCC110 | T | M | 50 | Bet+Tob | None | T2N0M0 | Well Diff | Norm |
OSCC129 | LG | M | 52 | F-Tob | L/M | T1N0M0 | Well Diff | Norm |
OSCC329 | LG | M | 59 | F-Tob | None | T4aN0M0 | Poorly Diff | Norm |
OSCC359 | T | M | 61 | Tob | Heavy | T4N2cM0 | Mod Diff | Norm |
OSCC416 | T | M | 61 | Tob | L/M | TcisN0M0 | N/A | Norm |
OSCC449 | LG | F | 62 | Tob | None | T4NoM0 | Mod Diff | Norm |
OSCC466 | T | M | 64 | Tob | Heavy | T2N0M0 | Poorly Diff | HIV positive |
OSCC485 | FOM | M | 56 | Tob | None | T4aN2bM0 | Mod Diff | Norm |
Sample | Site | Sex | Age | Tobacco/Betel | Ethanol | Path. Finding | Immune State | |
BL117 | LM | F | 46 | Tob | L/M | Canicular Adenoma | Norm | |
BL129 | Bu | M | 27 | Tob | None | Ameloblastoma | Norm | |
BL149 | LG | F | 54 | F-Tob | None | Hyperkeratosis | Norm | |
BL319 | T | F | 33 | Tob | L/M | Granular Cell Tumor | Norm | |
BL367 | Bu | M | 44 | ST | None | Hyperkeratosis, Mucositis | Norm | |
BL474 | LG | F | 77 | F-Tob | L/M | Fibrous hyperplasia | Norm | |
BL482 | T | M | 58 | Tob | L/M | Hyperkeratosis | Norm | |
BL490 | UG | M | 51 | Tob | L/M | Fibrous Hyperplasia | Norm | |
BL495 | UG | M | 60 | Tob | None | Hyperkeratosis | Norm |
aT, tongue; LG/UG lower/upper gingiva; FOM, floor of mouth; Bu, buccal mucosa, LM, lip mucosa.
bTob, Tobacco user; if former user than F-Tob.; Bet, betel use; ST, smokeless tobacco user
c L/M, light to moderate intake of ethanol up to 50 grams per day, Heavy, intake of ethanol > 50 g/day.
d well differentiated, Well Diff; moderately differentiated, Mod Diff; Poorly differentiated, Poorly Diff